Samik Pharmaceutical Company LTD. (KOSDAQ:014950)
South Korea
· Delayed Price · Currency is KRW
9,790.00
-250.00 (-2.49%)
At close: Apr 28, 2026
KOSDAQ:014950 Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Net Income | -754.89 | 3,522 | 2,969 |
| Depreciation & Amortization | 1,376 | 1,351 | 1,278 |
| Loss (Gain) From Sale of Assets | -45.98 | -9.5 | -0.07 |
| Asset Writedown & Restructuring Costs | - | 23.8 | - |
| Loss (Gain) From Sale of Investments | -348.99 | -300.14 | -298.32 |
| Stock-Based Compensation | 122.88 | 263.58 | 72.69 |
| Provision & Write-off of Bad Debts | -22.41 | -2.68 | -65.12 |
| Other Operating Activities | 5,084 | 1,391 | 696.68 |
| Change in Accounts Receivable | 3,825 | 558.63 | -1,117 |
| Change in Inventory | -3,212 | -2,105 | -55.64 |
| Change in Accounts Payable | -3,343 | 251.69 | -827.43 |
| Change in Income Taxes | - | - | -3.98 |
| Change in Other Net Operating Assets | -604.02 | -559.9 | -400.44 |
| Operating Cash Flow | 2,077 | 4,385 | 2,248 |
| Operating Cash Flow Growth | -52.64% | 95.04% | - |
| Capital Expenditures | -3,423 | -842.32 | -1,374 |
| Cash Acquisitions | 187.9 | - | - |
| Sale (Purchase) of Intangibles | -8.69 | -5.83 | -3.14 |
| Investment in Securities | 2,267 | -1,613 | -120.5 |
| Other Investing Activities | -21.95 | - | -70 |
| Investing Cash Flow | -1,153 | -2,161 | -1,868 |
| Long-Term Debt Repaid | -85.93 | -137.56 | -109.02 |
| Net Debt Issued (Repaid) | -85.93 | -137.56 | -109.02 |
| Issuance of Common Stock | 131.66 | 672.3 | - |
| Repurchase of Common Stock | -15.73 | - | - |
| Dividends Paid | -285.97 | -281 | -140.5 |
| Other Financing Activities | - | -1.02 | - |
| Financing Cash Flow | -255.98 | 252.72 | -249.52 |
| Foreign Exchange Rate Adjustments | 1.28 | - | - |
| Miscellaneous Cash Flow Adjustments | - | - | -0 |
| Net Cash Flow | 669.13 | 2,477 | 130.88 |
| Free Cash Flow | -1,346 | 3,543 | 874.05 |
| Free Cash Flow Growth | - | 305.32% | - |
| Free Cash Flow Margin | -2.24% | 6.34% | 1.71% |
| Free Cash Flow Per Share | -176.56 | 503.91 | 124.52 |
| Cash Interest Paid | 8.99 | 12.04 | 18.36 |
| Cash Income Tax Paid | 599.17 | 205.69 | 3.03 |
| Levered Free Cash Flow | -2,343 | 3,382 | - |
| Unlevered Free Cash Flow | -2,325 | 3,389 | - |
| Change in Working Capital | -3,334 | -1,854 | -2,405 |
Source: S&P Capital IQ. Standard template.
Financial Sources.